Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple Sites of the Cleavage of 21- and 25-Mer Encephalytogenic Oligopeptides Corresponding to Human Myelin Basic Protein (MBP) by Specific Anti-MBP Antibodies from Patients with Systemic Lupus Erythematosus.
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
Risk factors for idiopathic optic neuritis recurrence.
Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?
Reply to Article: High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis.
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
Multiple sclerosis genetics.
Development of the Cell Population in the Brain White Matter of Young Children.
Multiple sclerosis and family planning.
Early onset (childhood) monogenic neuropathies.
New data presented at 29th ECTRIMS congress reinforce the clinical profile of investigational laquinimod on disease progression and inflammation in relapsing-remitting multiple sclerosis
The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes.
Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection.
The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity.
Disability in multiple sclerosis: A reference for patients and clinicians.
Central Veins in Brain Lesions Visualized With High-Field Magnetic Resonance Imaging: A Pathologically Specific Diagnostic Biomarker for Inflammatory Demyelination in the Brain.
Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting.
Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
STAT3 Activates miR-155 in Th17 cells and Acts in Concert to Promote Experimental Autoimmune Uveitis.
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.
Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.
Sleep loss as risk factor for neurologic disorders: A review.
Platelets and autoimmunity.
Pages
« first
‹ previous
…
337
338
339
340
341
342
343
344
345
…
next ›
last »